Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

riversedge

(80,808 posts)
Wed Dec 14, 2022, 11:03 AM Dec 2022

Moderna's mRNA Cancer Vaccine Shows Promise in Preliminary Study

Caution. very early study. but I am optimistic --that someday soon scientists will find a cure for cancer--and better--a PREVENTION.




The Wall Street Journal. via msn

Moderna's mRNA Cancer Vaccine Shows Promise in Preliminary Study


https://www.wsj.com/articles/modernas-mrna-cancer-vaccine-shows-promise-in-preliminary-study-11670906379


Story by Peter Loftus • Yesterday 9:48 AM
173 Comments

Acustomized Moderna Inc. vaccine combined with a Merck & Co. cancer drug helped ward off the recurrence of the skin cancer melanoma after surgery in patients in a mid-stage clinical trial, the companies said.




WFXT
Moderna’s mRNA cancer vaccine shows promise in preliminary study
https://www.yahoo.com/now/moderna-mrna-cancer-vaccine-shows-134408952.html

1
Boston 25 News Staff
Tue, December 13, 2022 at 7:44 AM·1 min read



................
...........The patient group that took the potential vaccine and Keytruda saw a 44% reduction in the risk of death or the cancer returning, the companies said.
-

Merck and Moderna expect to start a phase 3 study of the combination next year. That’s generally the last and largest clinical study before a drug is submitted to regulators for approval.

The potential vaccine aims to train a patient’s immune system to recognize and respond specifically to mutations in their tumor. Keytruda, Merck’s top seller, primes the body’s immune system to detect and fight tumor cells.

Shares of Moderna jumped more than 8% in premarket trading, while Merck rose more than 2% and futures indexes increased slightly.

This is a developing story. Check back for updates as more information becomes available.

3 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Moderna's mRNA Cancer Vaccine Shows Promise in Preliminary Study (Original Post) riversedge Dec 2022 OP
When the vaccine is ready I wonder if some won't take it. Mosby Dec 2022 #1
Makes sense. I've seen much recent research comparing cancer to viruses. They both have specific kysrsoze Dec 2022 #2
GOOD republianmushroom Dec 2022 #3
 

Mosby

(19,491 posts)
1. When the vaccine is ready I wonder if some won't take it.
Wed Dec 14, 2022, 12:28 PM
Dec 2022

Thanks to people like DeSantis. Does he realize how irresponsible his ideas are?


kysrsoze

(6,446 posts)
2. Makes sense. I've seen much recent research comparing cancer to viruses. They both have specific
Wed Dec 14, 2022, 12:48 PM
Dec 2022

DNA, proteins, etc. If this pans out, it could make cancer what they're predicting, an illness treatable by medication, if it can't be completely cured.

Latest Discussions»Editorials & Other Articles»Moderna's mRNA Cancer Vac...